Shanghai Allist Pharmaceuticals Co., Ltd.

XSSC:688578 Stock Report

Market Cap: CN¥26.0b

Shanghai Allist Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 6/6

Shanghai Allist Pharmaceuticals has a total shareholder equity of CN¥4.9B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥5.4B and CN¥570.1M respectively. Shanghai Allist Pharmaceuticals's EBIT is CN¥1.3B making its interest coverage ratio -16.7. It has cash and short-term investments of CN¥3.0B.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ratio-16.7x
CashCN¥3.03b
EquityCN¥4.86b
Total liabilitiesCN¥570.05m
Total assetsCN¥5.43b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 688578's short term assets (CN¥3.8B) exceed its short term liabilities (CN¥544.3M).

Long Term Liabilities: 688578's short term assets (CN¥3.8B) exceed its long term liabilities (CN¥25.8M).


Debt to Equity History and Analysis

Debt Level: 688578 is debt free.

Reducing Debt: 688578 has no debt compared to 5 years ago when its debt to equity ratio was 12.6%.

Debt Coverage: 688578 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 688578 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies